Dawn L. Hershman, MD, Herbert Irving Comprehensive Cancer Center at Columbia University
Advertisement
Articles by Dawn L. Hershman, MD, Herbert Irving Comprehensive Cancer Center at Columbia University
Advertisement
Latest Updated Articles
Rapid Readouts: Updated Results From KX-ORAX-001 StudyDecember 23rd 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
MONUMENTAL-3 Data Support Talquetamab Plus Daratumumab ± Pomalidomide as a New SOC in R/R Myeloma
3
Luspatercept Misses Primary RBC-TI End Point But Shows Clinically Meaningful Improvement for Anemia in Myelofibrosis
4
CLL14 Final Analysis Shows Long-Term PFS Gain With Venetoclax/Obinutuzumab in Previously Untreated CLL
5